发明名称 FUSION POLYPETIDES CONTAINING IgE AND HSA, PROCESS OF THEIR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND THEIR USE
摘要 <p>Fusion polypeptides and salts thereof comprising at least one IgE-binding domain fused to at least one human serum albumin component, optionally via a peptide linker, and in particular, dimeric fusion polypeptides comprising HSA protein fused, at each of its amino and carboxy termini, to an extracellular domain of the alpha -chain of the human high affinity receptor for IgE (Fc epsilon RI alpha ); process for the preparation thereof, functionally equivalent polypeptides which are intermediates in their preparation, and polynucleotide and oligonucleotide intermediates and vectors therefor. They are indicated for use in the prevention and/or treatment of IgE-mediated allergic diseases and related disorders such as atopic dermatitis, atopic asthma and chronic urticaria.</p>
申请公布号 CZ9900246(A3) 申请公布日期 1999.04.14
申请号 CZ19990000246 申请日期 1997.07.25
申请人 NOVARTIS AG 发明人 DIGAN MARY ELLEN;LAKE PHILIP;GRAM HERMANN
分类号 A01K67/027;A61K38/00;A61K38/17;A61K39/395;A61K48/00;A61P37/08;C07K14/735;C07K14/765;C07K19/00;C12N1/19;C12N15/09;C12N15/12;C12N15/62;C12N15/64;C12N15/85;C12P21/02;C12R1/91;G01N33/53;(IPC1-7):C12N15/62;C12N15/81;A61K38/16;G01N33/68 主分类号 A01K67/027
代理机构 代理人
主权项
地址